Literature DB >> 26383540

Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.

Dallas Bednarczyk1, Carri Boiselle1.   

Abstract

1. Organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 are polyspecific transporters that mediate the transport of organic acids into hepatocytes. Inactivating mutations of both OATP1B1 and OATP1B3 alleles lead to Rotor syndrome, a disease characterized by coproporphyrinuria, an elevated urinary excretion of coproporphyrins I and III. It was hypothesized that transport of coproporphyrins I and III was mediated by OATP1B1 and OATP1B3. 2. This hypothesis was tested using cells transfected with OATP1B1 and OATP1B3. OATP1B-mediated transport of coproporphyrin was time-dependent and concentration-dependent. OATP1B1-mediated transport of coproporphyrins I and III (Km = 0.13 and 0.22 µM, respectively), as did OATP1B3 (Km = 3.25 and 4.61 µM, respectively). The OATP1B-mediated transport of each coproporphyrin was inhibited by rifampicin. 3. The specificity of coproporphyrin transport was also investigated where OATP2B1 demonstrated meaningful transport of coproporphyrin III (Km = 0.31 µM), while OCT1, OCT2, OAT1, OAT3 and NTCP were negative for coproporphyrin transport. 4. The identification of coproporphyrins as OATP substrates in vitro more clearly defines the role of OATPs in the hepatic disposition and renal excretion of coproporphyrins I and III and provides compelling evidence for future in vivo exploration of coproporphyrins as biomarkers of OATP activity.

Entities:  

Keywords:  Coproporphyrin; drug interaction; hyperbilirubinemia; organic anion transporting polypeptide; rotor syndrome

Mesh:

Substances:

Year:  2015        PMID: 26383540     DOI: 10.3109/00498254.2015.1085111

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  15 in total

1.  Clinical Investigation of Coproporphyrins as Sensitive Biomarkers to Predict Mild to Strong OATP1B-Mediated Drug-Drug Interactions.

Authors:  Annett Kunze; Emmanuel Njumbe Ediage; Lieve Dillen; Mario Monshouwer; Jan Snoeys
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

2.  OATP1B3 Expression and Function is Modulated by Coexpression with OCT1, OATP1B1, and NTCP.

Authors:  Yuchen Zhang; Melissa Ruggiero; Bruno Hagenbuch
Journal:  Drug Metab Dispos       Date:  2020-06-01       Impact factor: 3.922

Review 3.  Protein-protein interactions of drug uptake transporters that are important for liver and kidney.

Authors:  Yuchen Zhang; Bruno Hagenbuch
Journal:  Biochem Pharmacol       Date:  2019-08-02       Impact factor: 5.858

4.  PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3.

Authors:  Takashi Yoshikado; Kota Toshimoto; Kazuya Maeda; Hiroyuki Kusuhara; Emi Kimoto; A David Rodrigues; Koji Chiba; Yuichi Sugiyama
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-09-30

5.  Organic Anion Transporter Polypeptide 1B1 Polymorphism Modulates the Extent of Drug-Drug Interaction and Associated Biomarker Levels in Healthy Volunteers.

Authors:  Sook Wah Yee; Marilyn M Giacomini; Hong Shen; W Griffith Humphreys; Howard Horng; William Brian; Yurong Lai; Deanna L Kroetz; Kathleen M Giacomini
Journal:  Clin Transl Sci       Date:  2019-04-13       Impact factor: 4.689

6.  Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study.

Authors:  Hari V Kalluri; Ryota Kikuchi; Sheryl Coppola; Jeffrey Schmidt; Mohamed-Eslam F Mohamed; Daniel A J Bow; Ahmed H Salem
Journal:  Clin Transl Sci       Date:  2020-10-24       Impact factor: 4.689

7.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

8.  Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B-Mediated Drug-Drug Interactions Using Population Pharmacokinetic Modeling and Simulation.

Authors:  Shelby Barnett; Kayode Ogungbenro; Karelle Ménochet; Hong Shen; Yurong Lai; W Griffith Humphreys; Aleksandra Galetin
Journal:  Clin Pharmacol Ther       Date:  2018-01-17       Impact factor: 6.875

9.  Complex DDI by Fenebrutinib and the Use of Transporter Endogenous Biomarkers to Elucidate the Mechanism of DDI.

Authors:  Nicholas S Jones; Kenta Yoshida; Laurent Salphati; Jane R Kenny; Matthew R Durk; Leslie W Chinn
Journal:  Clin Pharmacol Ther       Date:  2019-09-16       Impact factor: 6.875

10.  Substantially Increased Plasma Coproporphyrin-I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population.

Authors:  Yosuke Suzuki; Yuri Sasamoto; Teruhide Koyama; Chisato Yoshijima; Masahiro Nakatochi; Michiaki Kubo; Yukihide Momozawa; Ritei Uehara; Keiko Ohno
Journal:  Clin Transl Sci       Date:  2020-10-05       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.